Wall Street is positive on IO Biotech Inc (IOBT). On average, analysts give IOBT a Strong Buy rating. The average price target is $20.5, which means analysts expect the stock to climb by 95.05% over the next twelve months.
That average ranking earns IOBT an Analyst Rating of 70, which is better than 70% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating IOBT a Strong Buy today. Find out what this means to you and get the rest of the rankings on IOBT!
Why are Analyst Ratings Important?
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With IO Biotech Inc Stock Today?
IO Biotech Inc (IOBT) stock is trading at $10.51 as of 11:27 AM on Wednesday, Dec 8, an increase of $0.38, or 3.72% from the previous closing price of $10.13. The stock has traded between $9.25 and $10.88 so far today. Volume today is low. So far 44,415 shares have traded compared to average volume of 332,713 shares.
Click Here to get the full Stock Report for IO Biotech Inc stock.